Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects

Abstract

Safety issues including side effects are one of the major factors causing failure of clinical trials in drug development. Here, the authors leverage information about phenotypes associated with variation in genes encoding drug targets to predict drug-treatment-related side effects.